Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

Overall, the reviewers wrote, most IBD therapies “appear safe and effective when used in chronic kidney disease, including on renal replacement therapy, particularly biologic therapies.” However, they ...

Expert panelists share final points of emphasis regarding treatment for CKD. Ryan Haumschild, PharmD, MS, MBA: Dr Nicholas, we’ve talked a lot about halting progression. What more can we do to delay ...

The FDA has authorized Mayo Clinic to offer mesenchymal stem cells as part of the Regenerative Nephrology Compassionate Use Program. This is an expanded access program.

Chronic kidney disease (CKD) has been called an “under-recognized public health crisis,” and is estimated to impact 14% of US adults. CKD patients typically have to undergo regular dialysis treatment ...

Please provide your email address to receive an email when new articles are posted on . Increased fat mass, particularly visceral adiposity, promotes kidney disease generation and progression through ...

The European Renal Association (ERA) kicks off its 61st ERA Congress in Stockholm, Sweden, with a theme of "Rethinking kidney health, transforming kidney care," and a program full of sessions delving ...

To begin to close the equity gap in diabetes, we must commit to designing therapies that account for the practical realities ...

Kidney disease is the third-fastest-growing cause of death globally. Here's why doctors are sounding the alarm. Kidney disease is a serious yet often overlooked condition that affects millions ...

Proteomics International Laboratories Ltd (ASX: PIQ) has announced the publication of a peer-reviewed Australian clinical ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Worries that ...